Ascendis Pharma A/s share price today

(ASND)

Ascendis Pharma A/s share price is $136.38 & ₹11,589.03 as on 21 Dec 2024, 2.30 'hrs' IST

$136.38

▲

-1.36

(-0.99%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Ascendis Pharma A/s share price in Dollar and Rupees. Guide to invest in Ascendis Pharma A/s from India. Also see the sentimental analysis on Indian investors investing in Ascendis Pharma A/s. Get details on the Indian mutual funds that are investing in Ascendis Pharma A/s. Get Analyst recommendations and forecasts along with all the Ascendis Pharma A/s's financials.

Ascendis Pharma A/s share price movements

Today's Low: $135.79
Today's High: $141.37
$136.38
0.43%
Downside
Day's Volatility :3.95%
Upside
3.53%
52 Weeks Low: $111.09
52 Weeks High: $161.00
$136.38
18.54%
Downside
52 Weeks Volatility :31.0%
Upside
15.29%

Ascendis Pharma A/s Returns

Period	Ascendis Pharma A/s	Sector (Health Care)	Index (Russel 2000)
3 Months	-6.97%	-11.1%	0.0%
6 Months	5.4%	-6.0%	0.0%
1 Year	7.28%	2.7%	0.0%
3 Years	-2.11%	0.6%	-19.7%

Ascendis Pharma A/s Key Statistics

in dollars & INR

Previous Close	$137.74
Open	$137.0
Today's High	$141.37
Today's Low	$135.79
Market Capitalization	$8.2B
Today's Volume	$686.3K
52 Week High	$161.0
52 Week Low	$111.09
Revenue TTM	$317.6M
EBITDA	$-347.2M
Earnings Per Share (EPS)	$-7.82
Profit Margin	-154.12%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-818.43%

How to invest in Ascendis Pharma A/s from India?

It is very easy for Indian residents to invest directly in Ascendis Pharma A/s from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ascendis Pharma A/s stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ascendis Pharma A/s or ASND on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ascendis Pharma A/s or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ascendis Pharma A/s shares which would translate to 0.006 fractional shares of Ascendis Pharma A/s as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Ascendis Pharma A/s, in just a few clicks!

Returns in Ascendis Pharma A/s for Indian investors in Rupees

Investment Value

₹1,00,000

Ascendis Pharma A/s investment value today

Current value as on today

₹1,09,480

Returns

₹9,480

(+9.48%)

Returns from Ascendis Pharma A/s Stock

₹7,284 (+7.28%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Ascendis Pharma A/s

-19%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Ascendis Pharma A/s on INDmoney from India has reduced in the last 30 days as on Dec 22, 2024. -19% less investors are searching Ascendis Pharma A/s in the last 30 days versus the previous period.

Global Institutional Holdings in Ascendis Pharma A/s

RA Capital Management, LLC
16.25%
Westfield Capital Management Company, L.P.
8.59%
venBio Select Advisor LLC
8.35%
FMR Inc
8.21%
Artisan Partners Limited Partnership
7.38%
HHG PLC
7.01%

Analyst Recommendation on Ascendis Pharma A/s

Buy

80%Buy

20%Hold

0%Sell

Based on 20 Wall street analysts offering stock ratings for Ascendis Pharma A/s(by analysts ranked 0 to 5 stars)

Based on 20 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Ascendis Pharma A/s

What analysts predicted

Upside of 39.41%

Current:

$136.38

Target:

$190.13

Insights on Ascendis Pharma A/s

Price Movement
In the last 7 days, ASND stock has moved up by 5.0%
Increasing Revenue
Revenue is up for the last 2 quarters, 35.99M → 57.83M (in $), with an average increase of 37.8% per quarter
Increasing Net Profit
Netprofit is up for the last 5 quarters, -162.22M → -99.19M (in $), with an average increase of 13.5% per quarter
ASND vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 23.5%
ASND vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 24.6%
Price to Sales
ForASND every $1 of sales, investors are willing to pay $24.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Ascendis Pharma A/s Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$12.0M	↑ 591.57%
Net Income	$-148.0M	↑ 5.0%
Net Profit Margin	-1.2K%	↑ 6868.31%

	FY19	Y/Y Change
Revenue	$14.9M	↑ 26.41%
Net Income	$-242.3M	↑ 67.58%
Net Profit Margin	-1.6K%	↓ 400.5%

	FY20	Y/Y Change
Revenue	$8.5M	↓ 48.01%
Net Income	$-509.6M	↑ 92.17%
Net Profit Margin	-6.0K%	↓ 4395.5%

	FY21	Y/Y Change
Revenue	$8.8M	↑ 11.87%
Net Income	$-433.6M	↓ 8.44%
Net Profit Margin	-4.9K%	↑ 1093.97%

	FY22	Y/Y Change
Revenue	$54.2M	↑ 557.93%
Net Income	$-617.2M	↑ 52.04%
Net Profit Margin	-1.1K%	↑ 3791.93%

	FY23	Y/Y Change
Revenue	$291.0M	↑ 421.2%
Net Income	$-525.2M	↓ 17.45%
Net Profit Margin	-180.51%	↑ 959.12%

	Q2 FY23	Q/Q Change
Revenue	$51.4M	↑ 0.0%
Net Income	$-131.7M	↑ 0.0%
Net Profit Margin	-256.23%	↑ 0.0%

	Q3 FY23	Q/Q Change
Revenue	$51.3M	↑ 1.35%
Net Income	$-173.2M	↑ 33.59%
Net Profit Margin	-337.73%	↓ 81.5%

	Q4 FY23	Q/Q Change
Revenue	$104.6M	↑ 99.64%
Net Income	$-142.9M	↓ 19.23%
Net Profit Margin	-136.65%	↑ 201.08%

	Q1 FY24	Q/Q Change
Revenue	$39.1M	↓ 62.46%
Net Income	$-118.9M	↓ 16.53%
Net Profit Margin	-303.85%	↓ 167.2%

	Q2 FY24	Q/Q Change
Revenue	$38.7M	↑ 0.0%
Net Income	$-117.7M	↑ 0.0%
Net Profit Margin	-303.85%	↑ 0.0%

	Q3 FY24	Q/Q Change
Revenue	$57.8M	↑ 60.66%
Net Income	$-99.2M	↓ 9.31%
Net Profit Margin	-171.52%	↑ 132.33%

	FY18	Y/Y Change
Profit	$12.0M	↑ 591.57%

	FY19	Y/Y Change
Profit	$14.9M	↑ 26.41%

	FY20	Y/Y Change
Profit	$8.5M	↓ 48.01%

	FY21	Y/Y Change
Profit	$4.8M	↓ 38.8%

	FY22	Y/Y Change
Profit	$41.3M	↑ 817.44%

	FY23	Y/Y Change
Profit	$242.5M	↑ 469.52%

	Q2 FY23	Q/Q Change
Profit	$37.4M	↑ 0.0%

	Q3 FY23	Q/Q Change
Profit	$43.4M	↑ 17.94%

	Q4 FY23	Q/Q Change
Profit	$96.4M	↑ 117.3%

	Q1 FY24	Q/Q Change
Profit	$26.7M	↓ 72.22%

	Q2 FY24	Q/Q Change
Profit	$26.4M	↑ 0.0%

	Q3 FY24	Q/Q Change
Profit	$46.6M	↑ 90.08%

	FY18	Y/Y Change
Operating Cash Flow	$-157.9M	↑ 45.96%
Investing Cash Flow	$-3.0M	↑ 181.4%
Financing Cash Flow	$231.2M	↑ 62.98%

	FY19	Y/Y Change
Operating Cash Flow	$-195.5M	↑ 26.75%
Investing Cash Flow	$-5.7M	↑ 94.83%
Financing Cash Flow	$548.5M	↑ 142.83%

	FY20	Y/Y Change
Operating Cash Flow	$-330.3M	↑ 54.34%
Investing Cash Flow	$-354.2M	↑ 5544.49%
Financing Cash Flow	$733.0M	↑ 22.09%

	FY21	Y/Y Change
Operating Cash Flow	$-472.1M	↑ 53.8%
Investing Cash Flow	$-125.0M	↓ 62.03%
Financing Cash Flow	$397.2M	↓ 41.69%

	FY22	Y/Y Change
Operating Cash Flow	$-524.6M	↑ 18.69%
Investing Cash Flow	$65.3M	↓ 155.83%
Financing Cash Flow	$419.9M	↑ 12.92%

	Q4 FY22	Q/Q Change
Operating Cash Flow	$-149.9M	↑ 43.36%
Investing Cash Flow	$-843.4K	↓ 105.65%
Financing Cash Flow	$1.4M	↓ 1875.0%

	Q1 FY23	Q/Q Change
Operating Cash Flow	$-163.9M	↑ 8.08%
Investing Cash Flow	$50.3M	↓ 5991.72%
Financing Cash Flow	$-2.5M	↓ 271.16%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-166.1M	↑ 0.0%
Investing Cash Flow	$50.9M	↑ 0.0%
Financing Cash Flow	$-2.5M	↑ 0.0%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-133.1M	↓ 18.55%
Investing Cash Flow	$23.7M	↓ 52.68%
Financing Cash Flow	$153.0M	↓ 6308.66%

Ascendis Pharma A/s Technicals Summary

Sell

Neutral

Buy

Ascendis Pharma A/s is currently in a neutral trading position according to technical analysis indicators.

Ascendis Pharma A/s Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Ascendis Pharma A/s	11.2%	5.4%	7.28%	-2.11%	3.78%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.38%	12.23%	86.41%
Biontech Se	4.48%	30.56%	7.97%	-55.71%	237.85%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.37%	26.29%	108.55%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-2.55%	77.79%	80.12%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Ascendis Pharma A/s	NA	NA	NA	-7.23	-8.18	-0.28	NA	-2.57
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Ascendis Pharma A/s	Buy	$8.2B	3.78%	NA	-154.12%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	86.41%	17.51	33.61%
Biontech Se	Buy	$26.7B	237.85%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	108.55%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.12%	32.84	-4.51%

Ascendis Pharma A/s Dividend announcements

Ascendis Pharma A/s Earnings
Ascendis Pharma A/s’s price-to-earnings ratio stands at None
Read More

About Ascendis Pharma A/s

ascendis pharma a/s is a biotechnology company located in 12 tuborg blvd., hellerup, capital region of denmark, denmark.

Organization	Ascendis Pharma A/s
Employees	879
CEO	Mr. Jan Moller Mikkelsen
Industry	Health Technology

Management People of Ascendis Pharma A/s

Name	Title
Mr. Jan Moller Mikkelsen	President, CEO, Member of Executive Board & Executive Director
Mr. Scott T. Smith	CFO, Executive VP & Member of Executive Board
Ms. Lotte Sonderbjerg	Executive VP, Chief Administrative Officer & Member of the Executive Board
Mr. Michael Wolff Jensen L.L.M.	Executive VP, Chief Legal Officer & Member of the Executive Board
Mr. Mads Bodenhoff	Senior VP of Finance & Principal Accounting Officer
Mr. Timothy J. Lee	Senior Director of Investor Relations
Mr. Flemming Steen Jensen	Executive Vice President of Product Supply & Quality
Dr. Kennett Sprogoe Ph.D.	Executive VP and Head of Research & Product Development
Dr. Stina Singel M.D., Ph.D.	Executive VP & Head of Clinical Development for Oncology
Mr. Joseph Kelly	Head of U.S. Commercial of Endocrinology

Important FAQs about investing in Ascendis Pharma A/s from India :

What is Ascendis Pharma A/s share price today?

Ascendis Pharma A/s share price today stands at $136.38, Open: $137.00 ; Previous Close: $137.74 ; High: $141.37 ; Low: $135.79 ; 52 Week High: $161.00 ; 52 Week Low: $111.09. The stock opens at $137.00, after a previous close of $137.74. The stock reached a daily high of $141.37 and a low of $135.79, with a 52-week high of $161.00 and a 52-week low of $111.09.

Can Indians buy Ascendis Pharma A/s shares?

Yes, Indians can invest in the Ascendis Pharma A/s (ASND) from India.

With INDmoney, you can buy Ascendis Pharma A/s at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Ascendis Pharma A/s at zero transaction cost.

How can I buy Ascendis Pharma A/s shares from India?

It is very easy to buy Ascendis Pharma A/s from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ascendis Pharma A/s be purchased?

Yes, you can buy fractional shares of Ascendis Pharma A/s with INDmoney app.

What are the documents required to start investing in Ascendis Pharma A/s stocks?

To start investing in Ascendis Pharma A/s, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.